Financial Data and Key Metrics Changes - The company reported a like-for-like growth of 13% in Q1 2020, indicating a strong start to the year despite the challenges posed by Covid-19 [15][19] - The company expects to perform better than originally anticipated for the year, although the outlook remains uncertain due to ongoing Covid-19 challenges [19][20] Business Line Data and Key Metrics Changes - Hygiene and health segments showed consistent growth, with brands like Dettol and Lysol experiencing exceptional and sustained growth due to increased usage and penetration [16][45] - The infant formula and nutrition (IFCN) business declined by 2% on a like-for-like basis, primarily due to a tough comparison with a stronger Q1 in 2019 and ongoing product transitions in China [17][39] - E-commerce sales grew over 50%, with total e-commerce sales exceeding 10% for the first time in Q1 [19] Market Data and Key Metrics Changes - North America saw strong growth driven by increased demand for hygiene products, particularly in March as consumers responded to Covid-19 [18] - Emerging markets experienced mid-single-digit growth overall, with specific challenges in India due to shutdowns and physical dislocations [50] Company Strategy and Development Direction - The company aims for mid-single-digit organic revenue growth and mid-20s margins by 2025, with a focus on executing its transformation strategy [9][20] - The organization is being restructured into three global business units: hygiene, health, and nutrition, with specific strategies for China and e-commerce [11] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the unprecedented challenges posed by Covid-19 but expressed confidence in the company's ability to adapt and respond to changing consumer needs [6][12] - The company is investing in capacity to meet growing demand and is focused on maintaining safety for employees while navigating operational challenges [20][36] Other Important Information - The company launched the RB Fight for Access Fund to support frontline health workers and communities, committing 1% of adjusted operating profit to various initiatives [14] - The company has made significant investments in supply chain agility and capacity to address the increased demand for its products [33][36] Q&A Session All Questions and Answers Question: Understanding growth numbers and new customer engagement - Management noted increased penetration and usage in hygiene categories, particularly for Dettol and Lysol, and emphasized the importance of customer engagement and service improvements [26][27] Question: Guidance on performance and margins - Management indicated that while there are uncertainties, they expect performance to be better than previously communicated, with some positive margin tailwinds from commodity costs and volume leverage [30][48] Question: Supply chain concerns and capital expenditure - Management reassured that supply chain planning has improved significantly, and while there are challenges, they are actively working to ramp up supply and manage investments [35][36] Question: Market share gains and R&D outlook - Management confirmed strong market share performance across various categories, driven by consumer trust in established brands, and emphasized the ongoing importance of R&D for future product development [72][73] Question: Infant nutrition in China and growth outlook - Management acknowledged the challenges in the infant nutrition segment but highlighted encouraging progress in premiumization and e-commerce strategies [74][75]

HEALTH · HYGIENE · HOME REJUVENATING SUSTAINABLE GROWTH 27th February 2020 (o Disclaimer Cautionary note concerning forward-looking statements This presentation contains statements with respect to the financial condition, results of operations and business of RB (the "Group") and certain of the plans and objectives of the Group that are forward-looking statements. Words such as ''intends', 'targets', or the negative of these terms and other similar expressions of future performance or results, and their neg ...

Financial Data and Key Metrics Changes - The company delivered top line growth of 0.8% on a like-for-like basis for the full year 2019, with adjusted EPS growth of 2.8% [6][21] - Operating margins experienced a modest decline, with adjusted operating margin decreasing by 50 basis points for the full year [30][49] - Total adjusted EPS growth was 1.8% in the second half and 2.8% for the full year, with a 3% to 4% headwind expected from currency movements in 2020 [21][49] Business Line Data and Key Metrics Changes - The Hygiene Home business unit reported a 4% growth in Q4 and for the full year, benefiting from strong brand performance [40][41] - The Health business unit faced challenges, with a reported revenue decline of 2.2% in Q4, attributed to supply chain difficulties and increased trade spend [32][34] - Mead Johnson, acquired for $17 billion, showed mixed performance, with strong growth in the U.S. but challenges in China leading to a noncash impairment of goodwill [8][9][22] Market Data and Key Metrics Changes - The competitive environment in China for Mead Johnson has become more challenging, with a decline in market share due to intensified regulation and competition [9][24] - The U.S. market showed strong performance in infant nutrition, while Latin America and ASEAN faced execution challenges [9][10] Company Strategy and Development Direction - The company aims to rejuvenate mid-single-digit growth and deliver superior value through a detailed three-phase plan funded by productivity improvements [55][56] - A commitment to invest around £2 billion over the next three years is outlined, focusing on enhancing productivity and innovation [56][57] - The strategic focus includes leveraging eCommerce and digital capabilities, particularly in developing markets [61][62] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2019 performance was unsatisfactory and does not reflect the company's growth ambitions [13] - The CEO emphasized the need for execution improvements and a focus on restoring growth and driving strong earnings [55][70] - The company is committed to addressing supply chain issues and enhancing operational efficiency to improve performance [70][71] Other Important Information - Free cash flow conversion fell to 87%, below the target of 100%, primarily due to exceptional spending on integration and restructuring [45][46] - The company plans to reduce expenditures previously envisaged under the RB 2.0 program, expecting a reduction of around £30 million to £35 million [28] Q&A Session Summary Question: What are the expectations for the Health business moving forward? - Management acknowledged the Health business faced challenges but highlighted opportunities for growth through improved execution and product development [32][34] Question: How does the company plan to address the competitive pressures in China? - The company plans to enhance its operational capabilities and focus on leveraging its strong brand equity to regain market share in China [9][10] Question: What is the outlook for eCommerce growth? - eCommerce is expected to continue growing significantly, with operations in over 40 countries and a growth rate of 30% per year [62]